stem-cell-congress-2018-scientifictracks

7 / 12

Page 45
conferenceseries.com
Volume 8 Journal of Stem Cell Research & Therapy
ISSN: 2157-7633 Stem Cell Congress 2018
October 08-09, 2018
October 08-09, 2018 | Zurich, Switzerland
10 th Annual Conference on
Stem Cell & Regenerative Medicine
Application of clinical grade hUC-MSCs in the treatment of uterine scars in rats
Shuzhen Wu and Xin Luo
Southern Medical University, China
Full thickness injuries of the uterus may trigger uterine scar formation after cesarean section, ultimately leading to a variety
of obstetrical complications or infertility. The main mechanisms of uterine scar formation involved in acute or chronic
inflammatory response, collagen deposition and muscle fiber regeneration. Now-a-days, few methods have adequately solved
these problems. Human umbilical cord derived mesenchymal stem cells (hUC-MSCs) have excellent function in immune
regulation, tissue regeneration and functional reconstruction and have shown great promise in clinical applications. The
objective of this study was to investigate the effect of hUC-MSCs construct on inflammation regulation, collagen degradation
and functional regeneration in rat uterine scars following full thickness excision of uterine walls. In our research, the clinical
grade hUC-MSCs would be prepared strictly following the international standards of the International Society for Stem Cell
Research (ISSCR). In order to establish a rat model of uterine scars, a 2.0 cm in length, full thickness incision of uterine walls
was performed around 0.5 cm from each uterine horn. A total of 100 rats were randomly assigned to five groups, including a
normal group (n = 20), eutocia group (n = 20), cesarean group (n = 20), control group (saline n = 20) and hUC-MSCs group
(n = 20) to investigate the effect of clinical grade hUC-MSCs treatments on the structure and function of uterine scars. Saline
or hUC-MSCs were injected surrounding each uterine scar, respectively. At days 15, 30, 60 and 90 post-transplantation, the
superparamagnetic iron oxide nanoparticles (SPIONs) labeled hUC-MSCs were detected and traced in vitro by MRI. The
planting, distribution and migration of hUC-MSCs in uterine scar were dynamically detected by MRI and fluorescence tracing
of the living image of a small animal. Haematoxylin eosin staining, Masson’s trichrome staining, immunofluorescence staining,
western blot and real-time PCR for collagen, matrix metallo proteinases, inflammatory factors, chemokine, bFGF, PDGF-BB
and VEGF were performed. We would like to find out the value of hUC-MSCs according to the research mechanism.
Figure 1: Effect of hUC-MSCs on inflammation regulation, collagen degradation and functional regeneration in rat uterine scars.
Recent Publications
1. Fan D, Xia Q, Wu S, Ye S, Liu L, Wang W, et al., (2018) Mesenchymal stem cells in the treatment of Cesarean section skin
scars: study protocol for a randomized, controlled trial. Trials 19(1):155.
2. Fan D, Wu S, Ye S, Wang W, Wang L, Fu Y, et al., (2018) Random placenta margin incision for control hemorrhage
during cesarean delivery complicated by complete placenta previa: a prospective cohort study. Journal of Maternal-Fetal
& Neonatal Medicine DOI: 10.1080/14767058.2018.1457638.
3. Liu Y, Fan D, Fu Y, Wu S, Wang W, Ye S, et al., (2018) Diagnostic accuracy of cystoscopy and ultrasonography in the
prenatal diagnosis of abnormally invasive placenta. Medicine (Baltimore) 97(15):e0438.
4. FanD, Wu S, Wang R, Huang Y, Fu Y, AiW, et al.,(2017) Successfully treated congenital cystic adenomatoidmalformation
by open fetal surgery: Acare-compliant case report of a 5-year follow-up and reviewof the literature.Medicine (Baltimore)
96(2):e5865.
Biography
Shuzhen Wu is currently an obstetrician in Southern Medical University Affiliated Maternal & Child Health Hospital of Foshan. She graduated with her Master’s degree in
Obstetric (2009-2011), and her undergraduate degree in Medicine (2004-2009) from Shantou University Medical College, China. Her academic and research interests lie
in high-risk obstetric, placenta previa, fetal in utero treatment, and regenerative medicine and stem cell clinical therapy.
Shuzhen Wu et al., J Stem Cell Res Ther 2018, Volume 8
DOI: 10.4172/2157-7633-C4-041